Literature DB >> 24567328

Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET.

Sebastian Vogel1, Madhumita Chatterjee, Katja Metzger, Oliver Borst, Tobias Geisler, Peter Seizer, Iris Müller, Andreas Mack, Susanne Schumann, Hans-Jörg Bühring, Florian Lang, Rüdiger V Sorg, Harald Langer, Meinrad Gawaz.   

Abstract

Recruitment of mesenchymal stem cells (MSC) following cardiac injury, such as myocardial infarction, plays a critical role in tissue repair and may contribute to myocardial recovery. However, the mechanisms that regulate migration of MSC to the site of tissue damage remain elusive. Here, we demonstrate in vitro that activated platelets substantially inhibit recruitment of MSC toward apoptotic cardiac myocytes and fibroblasts. The alarmin high mobility group box 1 (HMGB1) was released by platelets upon activation and mediated inhibition of the cell death-dependent migratory response through Toll-like receptor (TLR)-4 expressed on the MSC. Migration of MSC to apoptotic cardiac myocytes and fibroblasts was driven by hepatocyte growth factor (HGF), and platelet activation was followed by HMGB1/TLR-4-dependent down-regulation of HGF receptor MET on MSC, thereby impairing HGF-driven MSC recruitment. We identify a novel mechanism by which platelets, upon activation, interfere with MSC recruitment to apoptotic cardiac cells, a process that may be of particular relevance for myocardial repair and regeneration.

Entities:  

Keywords:  Cardiac Repair and Regeneration; Cell Migration; HMGB1; Mesenchymal Stem Cells; Myocardial Infarction; Platelets; Toll-like Receptors (TLR)

Mesh:

Substances:

Year:  2014        PMID: 24567328      PMCID: PMC4036247          DOI: 10.1074/jbc.M113.530287

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Platelet-bound P-selectin expression in patients with coronary artery disease: impact on clinical presentation and myocardial necrosis, and effect of diabetes mellitus and anti-platelet medication.

Authors:  K Stellos; B Bigalke; D Stakos; N Henkelmann; M Gawaz
Journal:  J Thromb Haemost       Date:  2009-10-23       Impact factor: 5.824

2.  The correlation between platelet activation markers and HMGB1 in patients with disseminated intravascular coagulation and hematologic malignancy.

Authors:  Shosaku Nomura; Shinya Fujita; Ryotaro Ozasa; Takahisa Nakanishi; Michihiko Miyaji; Shinichiro Mori; Tomoki Ito; Kazuyoshi Ishii
Journal:  Platelets       Date:  2011-03-26       Impact factor: 3.862

3.  CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model.

Authors:  Chang H Lee; Bhranti Shah; Eduardo K Moioli; Jeremy J Mao
Journal:  J Clin Invest       Date:  2010-08-02       Impact factor: 14.808

Review 4.  Sterile inflammation: sensing and reacting to damage.

Authors:  Grace Y Chen; Gabriel Nuñez
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

Review 5.  HMGB1 is a therapeutic target for sterile inflammation and infection.

Authors:  Ulf Andersson; Kevin J Tracey
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

6.  Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction.

Authors:  Céline Mias; Olivier Lairez; Elodie Trouche; Jérome Roncalli; Denis Calise; Marie-Hélène Seguelas; Catherine Ordener; Marie-Dominique Piercecchi-Marti; Nathalie Auge; Anne Negre Salvayre; Philippe Bourin; Angelo Parini; Daniel Cussac
Journal:  Stem Cells       Date:  2009-11       Impact factor: 6.277

7.  A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.

Authors:  Ruth S Waterman; Suzanne L Tomchuck; Sarah L Henkle; Aline M Betancourt
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

8.  TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection.

Authors:  Yue Wang; Aaron M Abarbanell; Jeremy L Herrmann; Brent R Weil; Mariuxi C Manukyan; Jeffrey A Poynter; Daniel R Meldrum
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

9.  Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro.

Authors:  Harald F Langer; Konstantinos Stellos; Caroline Steingen; Amrei Froihofer; Tanja Schönberger; Björn Krämer; Boris Bigalke; Andreas E May; Peter Seizer; Iris Müller; Friederike Gieseke; Dorothea Siegel-Axel; Sven G Meuth; Annette Schmidt; Hans P Wendel; Ingo Müller; Wilhelm Bloch; Meinrad Gawaz
Journal:  J Mol Cell Cardiol       Date:  2009-03-27       Impact factor: 5.000

Review 10.  Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction.

Authors:  Zhuzhi Wen; Shaoxin Zheng; Changqing Zhou; Jingfeng Wang; Tong Wang
Journal:  J Cell Mol Med       Date:  2011-05       Impact factor: 5.310

View more
  21 in total

Review 1.  Signaling pathways and intervention therapies in sepsis.

Authors:  Yun-Yu Zhang; Bo-Tao Ning
Journal:  Signal Transduct Target Ther       Date:  2021-11-25

Review 2.  The Fatal Circle of NETs and NET-Associated DAMPs Contributing to Organ Dysfunction.

Authors:  Helena Block; Jan Rossaint; Alexander Zarbock
Journal:  Cells       Date:  2022-06-14       Impact factor: 7.666

3.  Platelet-derived high-mobility group box 1 promotes recruitment and suppresses apoptosis of monocytes.

Authors:  Sebastian Vogel; Dominik Rath; Oliver Borst; Andreas Mack; Patricia Loughran; Michael T Lotze; Matthew D Neal; Timothy R Billiar; Meinrad Gawaz
Journal:  Biochem Biophys Res Commun       Date:  2016-07-20       Impact factor: 3.575

4.  Platelets at the crossroads of thrombosis, inflammation and haemolysis.

Authors:  Sebastian Vogel; Swee Lay Thein
Journal:  Br J Haematol       Date:  2018-01-30       Impact factor: 6.998

5.  Extracellular Cyclophilin A Augments Platelet-Dependent Thrombosis and Thromboinflammation.

Authors:  Saskia N I von Ungern-Sternberg; Sebastian Vogel; Britta Walker-Allgaier; Sascha Geue; Andreas Maurer; Anna-Maria Wild; Patrick Münzer; Madhumita Chatterjee; David Heinzmann; Elisabeth Kremmer; Oliver Borst; Patricia Loughran; Alma Zernecke; Matthew D Neal; Timothy R Billiar; Meinrad Gawaz; Peter Seizer
Journal:  Thromb Haemost       Date:  2017-11-30       Impact factor: 5.249

6.  Platelet-derived HMGB1 is a critical mediator of thrombosis.

Authors:  Sebastian Vogel; Rebecca Bodenstein; Qiwei Chen; Susanne Feil; Robert Feil; Johannes Rheinlaender; Tilman E Schäffer; Erwin Bohn; Julia-Stefanie Frick; Oliver Borst; Patrick Münzer; Britta Walker; Justin Markel; Gabor Csanyi; Patrick J Pagano; Patricia Loughran; Morgan E Jessup; Simon C Watkins; Grant C Bullock; Jason L Sperry; Brian S Zuckerbraun; Timothy R Billiar; Michael T Lotze; Meinrad Gawaz; Matthew D Neal
Journal:  J Clin Invest       Date:  2015-11-09       Impact factor: 14.808

7.  Valproic acid stimulates in vitro migration of the placenta-derived mesenchymal stem/stromal cell line CMSC29.

Authors:  Balta Al-Sowayan; Rosemary J Keogh; Mohammed Abumaree; Harry M Georgiou; Bill Kalionis
Journal:  Stem Cell Investig       Date:  2019-02-13

Review 8.  The Inflammatory Role of Platelets via Their TLRs and Siglec Receptors.

Authors:  Fabrice Cognasse; Kim Anh Nguyen; Pauline Damien; Archibald McNicol; Bruno Pozzetto; Hind Hamzeh-Cognasse; Olivier Garraud
Journal:  Front Immunol       Date:  2015-03-02       Impact factor: 7.561

9.  Cross talk of the first-line defense TLRs with PI3K/Akt pathway, in preconditioning therapeutic approach.

Authors:  Fatemeh Pourrajab; Mohammad Baghi Yazdi; Mojtaba Babaei Zarch; Mohammadali Babaei Zarch; Seyedhossein Hekmatimoghaddam
Journal:  Mol Cell Ther       Date:  2015-05-30

Review 10.  Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015).

Authors:  Aastha Singh; Abhishek Singh; Dwaipayan Sen
Journal:  Stem Cell Res Ther       Date:  2016-06-04       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.